INFLAMMATORY MYOPATHY
Clinical trials for INFLAMMATORY MYOPATHY explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY MYOPATHY trials appear
Sign up with your email to follow new studies for INFLAMMATORY MYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First-in-Human cell therapy tested for tough autoimmune cases
Disease control Recruiting nowThis is an early-stage safety study testing a new cell therapy called YTS109. It will give a single infusion of these cells to 18 adults with severe autoimmune diseases, like lupus or Sjogren's, that have not responded to standard treatments. The main goal is to see if the treatm…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
One-Shot gene therapy tested to halt devastating autoimmune attacks
Disease control Recruiting nowThis early-stage study is testing a new, one-time treatment called TI-0032-III for people with severe autoimmune diseases like lupus and scleroderma that haven't improved with standard drugs. The treatment uses an injection to genetically reprogram the patient's own immune cells …
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Experimental cell therapy tested on patients with untreatable autoimmune diseases
Disease control Recruiting nowThis is an early-stage safety study testing a single infusion of YTS109 cells in 18 adults with severe autoimmune diseases that have not responded to standard treatments. The main goal is to check for side effects and see how the body handles the cells. Researchers will also look…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New cell therapy tested for patients Who've tried everything else
Disease control Recruiting nowThis is an early safety study testing a single infusion of a new cell therapy called YTS109. It aims to see if the treatment is safe and shows any signs of helping adults with severe autoimmune diseases that have not responded to standard treatments. The study will enroll about 1…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
One-Shot cell therapy tested as potential reset for stubborn autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a single infusion of 'universal' CAR T-cells in adults with severe autoimmune diseases like lupus and scleroderma that have not improved with standard treatments. The therapy aims to target and remove harmful immune cells to potentially control t…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New cell therapy tested for patients with untreatable autoimmune diseases
Disease control Recruiting nowThis is an early-stage study to check the safety of a new cell therapy called YTS109 for adults with severe autoimmune diseases that have not responded to standard treatments. About 18 participants with conditions like lupus, scleroderma, or vasculitis will receive a single infus…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Patients take charge: global study lets myositis community set research agenda
Knowledge-focused Recruiting nowThis study aims to understand what research matters most to people living with rare muscle diseases called myositis. Researchers will collect perspectives from 700 patients and caregivers worldwide through online surveys and discussions. The goal is to create a list of patient-pr…
Matched conditions: INFLAMMATORY MYOPATHY
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC